FDA approves Agios Pharmaceuticals’ TIBSOVO for acute myeloid leukemia

The US Food and Drug Administration (FDA) has granted approval to Agios Pharmaceuticals’ TIBSOVO (ivosidenib) for the treatment of adult patients with acute myeloid leukemia ... Read More